Unlearn.AI
- Headquarters
- San Francisco, California
- Website
- unlearn.ai
- Total Funding
- $116.8M
- Last Round
- $50.0M Series CFeb 2024
- Rounds
- 5
About
Unlearn.AI is the only company creating TwinRCTs™, which combine AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials. Unlearn's technology has been published in conference abstracts and scientific journals, including Scientific Reports - Nature and The International Journal of Biostatistics. Unlearn is partnering with the world's leading pharma companies, including Merck KGaA, Darmstadt, Germany, and continues to have discussions with regulators. Th
Funding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account